2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation

Non-viral gene delivery methods are changing the paradigm of genetic medicine by offering safer, more flexible, and scalable alternatives to viral-based systems. Our scientific sessions cover the novel delivery platforms, including lipid nanoparticles, polymer-based vectors, and large-scale production, which allow for precise and efficient delivery of genetic material.

At our USA Cell & Gene Therapy World Conference, leading investigators in the field of molecular biology, bioengineering, and translational medicine will present the latest advancements in non-viral delivery technologies. The conversations will be focused on vector optimization, large-scale manufacturing, regulatory challenges, and clinical translation, all while ensuring safety and therapeutic efficacy.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis